Breen J J, Matsuura T, Ross A C, Gurr J A
Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
Endocrinology. 1995 Feb;136(2):543-9. doi: 10.1210/endo.136.2.7835286.
T3 inhibits transcription of the rat TSH beta gene, and two T3 response elements have been identified that bind T3 receptors and that share sequence homology with the consensus sequence that is also recognized by retinoic acid receptors (RARs). We, therefore, asked whether RA was a regulator of TSH beta gene expression in vivo. Using RNase protection analysis, we found that vitamin A deficiency led to a 2-fold increase in rat pituitary TSH beta messenger RNA (mRNA) levels, which returned to normal 18 h after treatment with RA (20 micrograms/rat). Vitamin A deficiency had no effect on TSH beta mRNA levels in hypothyroid rats. Coadministration of RA and T3 (10 micrograms/100g body wt) to either vitamin A-deficient or vitamin A-deficient, hypothyroid animals caused decreases in TSH beta mRNA content that were indistinguishable from those seen with T3 alone. Surprisingly, vitamin A deficiency had no significant effect on GH mRNA levels in euthyroid or hypothyroid rats. Furthermore, treatment of vitamin A-deficient, hypothyroid animals with RA for either 18 or 72 h had no effect on GH mRNA levels, whereas T3 caused 11-fold and 18-fold increases in GH mRNA, respectively, at these times. We also used transient transfection to test for direct, retinoid receptor-mediated regulation of TSH beta gene transcription by RA. A plasmid TSH beta luciferase, containing 0.8 kilobases of rat TSH beta gene 5'-flanking sequences, exon 1, and 150 base pairs of intron 1, was transfected into CV-1 cells. Cotransfection with RAR alpha and retinoid X receptor-beta induced TSH beta expression by 3.5-fold, and treatment with RA suppressed this induction by 46%. These results show that vitamin A levels play a significant role in regulating the expression of the TSH beta gene, but not the GH gene, in vivo and suggest that RA may suppress TSH beta gene transcription directly by an RAR-retinoid X receptor heterodimer-mediated mechanism.
三碘甲状腺原氨酸(T3)抑制大鼠促甲状腺激素β(TSHβ)基因的转录,并且已鉴定出两个三碘甲状腺原氨酸反应元件,它们可结合三碘甲状腺原氨酸受体,且与视黄酸受体(RARs)识别的共有序列具有序列同源性。因此,我们探究视黄酸(RA)在体内是否为TSHβ基因表达的调节因子。通过核糖核酸酶保护分析,我们发现维生素A缺乏导致大鼠垂体TSHβ信使核糖核酸(mRNA)水平增加2倍,在用视黄酸(20微克/只大鼠)处理18小时后恢复正常。维生素A缺乏对甲状腺功能减退大鼠的TSHβ mRNA水平没有影响。给维生素A缺乏或维生素A缺乏且甲状腺功能减退的动物同时给予视黄酸和三碘甲状腺原氨酸(10微克/100克体重),导致TSHβ mRNA含量降低,这与单独使用三碘甲状腺原氨酸时的情况无明显差异。令人惊讶的是,维生素A缺乏对甲状腺功能正常或甲状腺功能减退大鼠的生长激素(GH)mRNA水平没有显著影响。此外,用视黄酸处理维生素A缺乏且甲状腺功能减退的动物18小时或72小时,对GH mRNA水平没有影响,而在这些时间点,三碘甲状腺原氨酸分别使GH mRNA增加11倍和18倍。我们还使用瞬时转染来测试视黄酸对视黄酸受体介导的TSHβ基因转录的直接调节作用。将含有0.8千碱基大鼠TSHβ基因5'侧翼序列、外显子1和150个碱基对内含子1的质粒TSHβ荧光素酶转染到CV-1细胞中。与RARα和视黄酸X受体β共转染诱导TSHβ表达增加3.5倍,而用视黄酸处理可使这种诱导作用抑制46%。这些结果表明,维生素A水平在体内调节TSHβ基因而非GH基因的表达中起重要作用,并提示视黄酸可能通过RAR-视黄酸X受体异二聚体介导的机制直接抑制TSHβ基因转录。